Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL25278948

NCc1nn(C2CCC(F)(F)CC2)c2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 1/20 0.51
▸ TEAD4 Q15561 1/20 0.51
▸ TEAD2 Q15562 1/20 0.51
▸ KDM5A P29375 1/20 0.39
▸ KDM4C Q9H3R0 1/20 0.39
▸ KDM5B Q9UGL1 1/20 0.39
▸ KCNJ6 P48051 1/20 0.38
▸ KCNJ5 P48544 1/20 0.38
▸ KCNJ3 P48549 1/20 0.38
▸ WHR1 P49842 1/20 0.37
▸ TPSAB1 Q15661 9/20 0.37
▸ PTGDR2 Q9Y5Y4 3/20 0.36
▸ CHRNA7 P36544 1/20 0.35
▸ F2 P00734 1/20 0.35
▸ PLAU P00749 1/20 0.35
▸ ELANE P08246 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3R2 O00459 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25236489 0.81 TEAD1 (0.52) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL25678129 0.78 TEAD1 (0.53) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL25234036 0.75 TEAD1 (0.46) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL30469084 0.75 TEAD1 (0.46) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL30469098 0.75 TEAD1 (0.46) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL25678135 0.75 TEAD1 (0.46) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL25278947 0.74 TEAD1 (0.39) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL29195498 0.74 TEAD1 (0.42) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL30856671 0.74 TEAD1 (0.42) TEAD1TEAD4TEAD2KDM5AKDM4C
SCHEMBL30469109 0.72 TEAD1 (0.42) TEAD1TEAD4TEAD2KDM5AKDM4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452936-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD The Katholieke Universiteit Leuven (BE) 2024-10-30 — — EP disclosed
WO-2023122782-A2 INDOLES, INDAZOLES, AND RELATED ANALOGS FOR INHIBITING YAP/TAZ-TEAD THE KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-06-29 — — WO disclosed
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD CISTIM LEUVEN VZW (BE) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202985-A1 Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD YAP1, TEAD2, TEAD3 TEAD1 4/4885TEAD4 5/4885TEAD2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback